Literature DB >> 27248572

Bariatric Surgery for Patients With Early-Onset vs Late-Onset Type 2 Diabetes.

Lwin Aung1, Wei-Jei Lee2, Shu Chun Chen2, Kong-Han Ser2, Chun-Chi Wu2, Keong Chong3, Yi-Chih Lee4, Jung-Chien Chen2.   

Abstract

IMPORTANCE: The prevalence of early-onset type 2 diabetes mellitus (T2DM), which responds poorly to medical treatment, is increasing. Bariatric surgery has been well recognized for its effectiveness in the remission of T2DM, but its effectiveness and durability in the remission of early-onset T2DM has not yet been explored.
OBJECTIVE: To compare the short- and long-term outcomes of bariatric surgery with a specific focus on the rate of remission of T2DM in patients with early-onset (age <40 years) and late-onset (age ≥40 years) T2DM. DESIGN, SETTING, AND PARTICIPANTS: In this cohort study, 558 Taiwanese patients (339 with early-onset T2DM and 219 with late-onset T2DM) with a body mass index (calculated as weight in kilograms divided by height in meters squared) above 25 underwent bariatric surgery to ameliorate T2DM between January 1, 2007, and December 31, 2013. Patients were followed up for at least 1 year. Preoperative, perioperative, and postoperative clinical and laboratory data were prospectively collected and compared between the 2 groups. MAIN OUTCOMES AND MEASURES: Rate of remission of T2DM (hemoglobin A1C <6.0% without antiglycemic medication) was the primary outcome measure.
RESULTS: Of the 558 patients (345 women) in the study, mean (SD) ages were 33.5 (7.5) for those with early-onset T2DM and 50.6 (6.5) with late onset T2DM. Those with early-onset T2DM had higher mean (SD) preoperative BMI and hemoglobin A1C values (39.4 [8.5] and 8.7% [3.8%] of total hemoglobin [to convert hemoglobin to a proportion of total hemoglobin, multiply by 0.01], respectively) than did patients with late-onset T2DM (36.7 [7.5] and 8.2% [1.6%], respectively). Distribution of surgical procedures and major complications were similar between the 2 groups. At 1 year, patients with early-onset T2DM achieved greater weight loss than those with late-onset T2DM, although the difference was not statistically significant. A higher rate of complete remission of T2DM was observed in patients with early-onset T2DM than in those with late-onset disease (193 [56.9%] vs 110 [50.2%]; P = .02). At 5 years, patients with early-onset T2DM still maintained a higher rate of weight loss (mean [SD], 30.4% [11.8%] vs 21.6% [11.7%]; P = .002) and higher rate of remission (47 of 72 [65.3%] vs 26 of 48 [54.2%]; P = .04) than did those with late-onset disease. Age at bariatric surgery, duration of T2DM, and preoperative C-peptide level were independent predictors of remission. The remission rate was directly related to extent of weight loss. Multivariate analysis confirmed the higher rate of remission in the group with early-onset T2DM. CONCLUSIONS AND RELEVANCE: This article describes the largest long-term study examining bariatric surgery for patients with early-onset T2DM. Bariatric surgery may achieve better and more long-lasting glycemic control in select patients with early-onset T2DM than in those with late-onset T2DM.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27248572     DOI: 10.1001/jamasurg.2016.1130

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


  10 in total

Review 1.  The Role of GLP-1 in the Metabolic Success of Bariatric Surgery.

Authors:  Chelsea R Hutch; Darleen Sandoval
Journal:  Endocrinology       Date:  2017-12-01       Impact factor: 4.736

2.  Diabetes Remission Status During Seven-year Follow-up of the Longitudinal Assessment of Bariatric Surgery Study.

Authors:  Jonathan Q Purnell; Elizabeth N Dewey; Blandine Laferrère; Faith Selzer; David R Flum; James E Mitchell; Alfons Pomp; Walter J Pories; Thomas Inge; Anita Courcoulas; Bruce M Wolfe
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

Review 3.  Glucagon-Like Peptide-1: Actions and Influence on Pancreatic Hormone Function.

Authors:  Ellen M Davis; Darleen A Sandoval
Journal:  Compr Physiol       Date:  2020-03-12       Impact factor: 8.915

Review 4.  Mechanisms for the metabolic success of bariatric surgery.

Authors:  Darleen A Sandoval
Journal:  J Neuroendocrinol       Date:  2019-04-10       Impact factor: 3.870

Review 5.  Metabolic Surgery for Type 2 Diabetes Mellitus: Experience from Asia.

Authors:  Wei Jei Lee; Lwin Aung
Journal:  Diabetes Metab J       Date:  2016-12       Impact factor: 5.376

6.  Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study.

Authors:  Anders Jans; Ingmar Näslund; Johan Ottosson; Eva Szabo; Erik Näslund; Erik Stenberg
Journal:  PLoS Med       Date:  2019-11-20       Impact factor: 11.069

Review 7.  Clinical epigenetics and restoring of metabolic health in severely obese patients undergoing batriatric and metabolic surgery.

Authors:  Mario Faenza; Giuditta Benincasa; Ludovico Docimo; Giovanni Francesco Nicoletti; Claudio Napoli
Journal:  Updates Surg       Date:  2021-10-02

Review 8.  Surgical treatment of obesity.

Authors:  Vance L Albaugh; Naji N Abumrad
Journal:  F1000Res       Date:  2018-05-21

9.  High plasma renin activity associates with obesity-related diabetes and arterial hypertension, and predicts persistent hypertension after bariatric surgery.

Authors:  Lucia La Sala; Elena Tagliabue; Elaine Vieira; Antonio E Pontiroli; Franco Folli
Journal:  Cardiovasc Diabetol       Date:  2021-06-09       Impact factor: 9.951

10.  Remission, relapse, and risk of major cardiovascular events after metabolic surgery in persons with hypertension: A Swedish nationwide registry-based cohort study.

Authors:  Erik Stenberg; Richard Marsk; Magnus Sundbom; Johan Ottosson; Tomas Jernberg; Ingmar Näslund; Erik Näslund
Journal:  PLoS Med       Date:  2021-11-01       Impact factor: 11.069

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.